e-learning
resources
Munich 2006
Tuesday 05.09.2006
Hospital-acquired pneumonia: from inflammation to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Acinetobacter baumanii
as a severity marker in a respiratory ICU
G. Brum, R. Macedo, J. Vizcaino, P. Azevedo, J. Monteiro, F. Monteiro, R. Soto-Mayor, A. Bugalho de Almeida (Lisbon, Portugal)
Source:
Annual Congress 2006 - Hospital-acquired pneumonia: from inflammation to treatment
Session:
Hospital-acquired pneumonia: from inflammation to treatment
Session type:
Poster Discussion
Number:
4502
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Brum, R. Macedo, J. Vizcaino, P. Azevedo, J. Monteiro, F. Monteiro, R. Soto-Mayor, A. Bugalho de Almeida (Lisbon, Portugal).
Acinetobacter baumanii
as a severity marker in a respiratory ICU. Eur Respir J 2006; 28: Suppl. 50, 4502
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Prognosis of
Acinetobacter baumannii
bacteraemia in a respiratory ICU: 10 years‘ experience
Source: Eur Respir J 2005; 26: Suppl. 49, 222s
Year: 2005
Acinetobacter baumani
and
Pseudomonas aeruginosa
drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003
Acinetobacter baumannii infection and colonization among pediatric patients in pediatric ICU and other ICUs
Source: International Congress 2018 – Neonatology and paediatric intensive care
Year: 2018
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
Source: Eur Respir J 2007; 29: 548-560
Year: 2007
Association of
acinetobacter baumannii
respiratory isolates with hospital outcomes in ventilated patients
Source: Eur Respir J 2006; 28: Suppl. 50, 785s
Year: 2006
Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults.
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017
Potential treatment for nosocomial respiratory strains of extreme drug resistant
acinetobacter baumanii
Source: Eur Respir J 2007; 30: Suppl. 51, 410s
Year: 2007
Antibiotic sensitivity of pseudomonas aeroginosa isolates of respiratory secretions taken from ICU patients of the NRITLD
Source: Eur Respir J 2004; 24: Suppl. 48, 641s
Year: 2004
The mortality of Acinetobacter baumanni infection in intensive care unit
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
Source: Eur Respir J 2010; 35: 598-615
Year: 2010
Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection
Source: Eur Respir J 2005; 25: 911-914
Year: 2005
Respiratory infections caused by
Pseudomonas aeruginosa
in patients admitted in a respiratory care unit
Source: Eur Respir J 2005; 26: Suppl. 49, 187s
Year: 2005
Resistant and panresistant
A. baumanni
infection in ICU
Source: Annual Congress 2010 - Intensive care unit outcome
Year: 2010
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Aetiopathogenesis of VAP revisited
Source: Eur Respir Mon 2011; 53: 1-10
Year: 2011
Carbapenem-resistant pathogens in US patients hospitalized with respiratory infections
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
Factors associated with mortality in ventilator associated pneumonia of multidrug resistant acinetobacter baumannii
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
The clinical evaluation of patients with Pseudomonas aeruginosa detected in respiratory specimens
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
Clinical outcomes of tigecycline in the treatment of critically ill patients with multidrug-resistant Acinetobactor baumannii infection
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
Nosocomial outbreak of OXA-48-producing Klebsiella pneumoniae in a respiratory intensive care unit
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept